Gilead Sciences, Inc. announced topline results from the Phase 3 SIMPLE trial in hospitalized patients with moderate COVID-19 pneumonia. This...
Read moreOxford Biomedica plc, a leading gene and cell therapy group, announced that it has signed a Collaboration Agreement with the...
Read moreKite, a Gilead Company announced it has received approval to implement a variation to the Yescarta® (axicabtagene ciloleucel) Marketing Authorization...
Read moreIntegrity Bio has announced the validation of its second fill/finish manufacturing line. This plant expansion more than doubles the company’s...
Read moreCorning Incorporated will receive $204 million from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of...
Read moreFUJIFILM Corporation will make a major capital investment of approximately 100 billion yen (928 million USD) in the Denmark site...
Read moreIn the absence of ‘in person’ meetings, access to deep dive pharma insights are not on hold, and later this...
Read moreWith Health Canada and the Food and Drug Administration beginning to approve and reimburse cell and gene therapies in significant...
Read morePOINT Biopharma (POINT) announced plans today to establish its first U.S. manufacturing facility in Indianapolis. “Indiana has established itself as...
Read moreCytiva’s Fast Trak process development team will use their expertise to develop a scalable downstream protein purification method for Entos...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.